Metastatic Hormone Sensitive Prostate Cancer trials recruiting in Ohio

Fewer than 3 recruiting trials found.

All Metastatic Hormone Sensitive Prostate Cancer trials nationally

Cities in Ohio

Recruiting trials in Ohio

• A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
  NCT07005154 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Ohio: Cincinnati
• A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics
  NCT07406282 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · Ohio: Cleveland